Evidence map›Paper›PMID 35310701›Full record

ArticleDEN open2022

The skill qualification system for portal hypertension in Japan.

Masayuki Ohta, Naoya Murashima, Tetsuji Ohyama, Tomoharu Yoshida, Shozo Hirota, Hirofumi Kawanaka, Makoto Hashizume, Shinichi Nakamura, Fumio Chikamori, Susumu Eguchi and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in DEN open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Masayuki OhtaGlobal Oita Medical Advanced Research Center for Health Oita University Oita Japan.ORCID https://orcid.org/0000-0003-4014-5493
Naoya MurashimaDepartment of Gastroenterology Mishuku Hospital Tokyo Japan.
Tetsuji OhyamaBiostatistics Center Kurume University Fukuoka Japan.
Tomoharu YoshidaKitakyushu Kokura Hospital Fukuoka Japan.
Shozo HirotaDepartment of Radiology Konan Medical Center Hyogo Japan.
Hirofumi KawanakaClinical Research Institute and Department of Surgery National Hospital Organization Beppu Medical Center Oita Japan.
Makoto HashizumeKitakyushu Koga Hospital Fukuoka Japan.
Shinichi NakamuraInstitute of Gastroenterology Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.
Fumio ChikamoriDepartment of Surgery Japanese Red Cross Kochi Hospital Kochi Japan.
Susumu EguchiDepartment of Surgery Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Takashi TajiriNippon Medical School Tokyo Japan.
Katsutoshi ObaraFukushima Preservative Service Association of Health Fukushima Japan.
Shigehiro KokubuCenter for Liver Disease Minimal Invasive Treatment Shin-Yurigaoka General Hospital Kanagawa Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The diverse treatments available for portal hypertension require specialized knowledge of hemodynamics and include endoscopic treatments, interventional radiology (IVR), and surgery. The Japan Society for Portal Hypertension has developed the skill qualification system (SQS) for portal hypertension and began examination in 2014. Here, the status and validity of the judgment of the SQS examination were evaluated. Methods: From 2014 to 2020, 79 applicants were evaluated by the SQS for portal hypertension. Each unedited video submitted as a candidate procedure was evaluated by two judges, and a grade of greater than 70% for the scoring items assessed by the judges was required to pass the examination. Inter-rater agreement of success/failure between the two judges was investigated by the AC Results: The results of two judges differed for 11 of the 79 videos (13.9%), and five applicants (6.3%) ultimately failed the examination. The percentages of total points received by the applicants with endoscopic treatments, IVR, and surgery were 87.3%, 79.4%, and 80.8%, respectively. There were significant differences in the percentages between endoscopic treatments and IVR ( Conclusions: The SQS for portal hypertension of the Japan Society for Portal Hypertension showed high reliability for video assessments by the judges. This system may contribute to the spread and further development of safe and effective treatments for portal hypertension in Japan.

Indexed as

endoscopic treatmentinterventional radiologyportal hypertensionskill qualification systemsurgery

Identifiers

PMID35310701
PMCPMC8828245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.